INSIGHTS ON CLINICAL TRIAL PARTNERING

• Evidence Of An Industry's Readiness To Collaborate

  The effort to build a single home for sites to access their trial systems has demonstrated that the industry is ready to forego competitive discourse to deliver benefits to sites and patients.

• From Legacy To Lifeline: Advancing Rare Disease Care

  Learn about inspiring figures who lived with rare diseases, get a look at today’s rare disease research, and see how we support patients around the world in this eBook.

• More Than Technology: How People Make The Difference For Customers

  Technology alone doesn’t guarantee success. Here, we explain how integrated processes, skilled teams, and collaborative partnerships complement innovation to reduce risk and improve patient outcomes.

• Two Views Of Risk When Choosing An IRT/RTSM Software Partner

  In this clip, Ryan Keane of Korio explains why legacy RTSM vendors, designed for large pharmaceutical companies, often struggle to serve smaller, fast-moving Sponsors.

• Unanticipated Roadblocks In Ovarian Cancer Drug Development

  3/9/2026

  Enhance your Ovarian cancer trials by enabling community referral pipelines, aligning imaging with biomarker assessments, and selecting sites based on verifiable surgical capacity.

• Podcast―Nonclinical Considerations When Developing Ophthalmic Drugs

  2/20/2025

  Globally recognized consultants discuss how they are addressing the most pressing drug development topics in the ocular field.

• Rethinking Trial Access Through Trust-Driven Design And Local Collaboration

  5/19/2026

  Locally embedded research models help sponsors reach underserved populations while reducing burden on patients and health systems alike.

• How Sponsors, CROs, And Tech Vendors Can Reduce Site Tech Overload

  10/10/2024

  Sites juggle dozens of applications, which increases their workload and limits their capacity. Sites need an industry-wide single sign-on experience that brings key systems and applications under one roof.

• European Clinical Trial Support Has To Work Country By Country

  7/8/2026

  Cross-border trial access looks easy in policy, but patients face real barriers: travel, documents, reimbursement, language. Plan the support model before recruitment begins so eligible patients can actually participate